Authors | Country | Year | Citations | Title | Journal |
---|---|---|---|---|---|
Xia, T. et al. | USA, Germany | 2008 | 1807 | Comparison of the Mechanism of Toxicity of Zinc Oxide and Cerium Oxide Nanoparticles Based on Dissolution and Oxidative Stress Properties | ACS nano |
Grobner, T. | Austria | 2006 | 1284 | Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? | Nephrology, Dialysis, Transplantation |
McDonald, R.J. et al. | USA | 2015 | 891 | Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging | Radiology |
Witzig, T.E. et al. | USA | 2002 | 846 | Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin’s lymphoma | Journal of Clinical Oncology |
McCrohon, A. et al. | UK, Germany | 2003 | 754 | Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance | Circulation |
Salem, R. et al. | USA | 2010 | 684 | Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes | Gastroenterology |
Celardo, I. et al. | Italy, Japan | 2011 | 656 | Pharmacological potential of cerium oxide nanoparticles | Nanoscale |
Heckert, E.G. Et al. | USA | 2008 | 655 | The role of cerium redox state in the SOD mimetic activity of nanoceria | Biomaterials |
Kanda, T. et al. | Japan | 2015 | 586 | Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy | Radiology |
Schubert, D. et al. | USA | 2006 | 551 | Cerium and yttrium oxide nanoparticles are neuroprotective | Biochemical and Biophysical Research Communications |